Leading the Way in Immuno-Oncology
Bristol-Myers Squibb is committed to discovering, developing and delivering innovative medicines for the treatment of cancer. Our pipeline in oncology is robust, with several experimental anticancer compounds in development. It is also diverse, reflecting a range of modalities and research programs. One such area is immuno-oncology.
Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. We are at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers.
Bristol-Myers Squibb has been on the leading edge of cancer treatment and continues to be committed to developing and studying investigational compounds as potential treatment options. If you are interested in exploring opportunities in immuno-oncology, search the current oncology opportunities available in oncology jobs at Bristol-Myers Squibb.
Bristol-Myers Squibb is an equal opportunity employer -- Vet/Disability
EEO is the LAW and Supplemental Information
Learn more about our commitment to EEO.